Close Menu

NEW YORK – Cancer Genetics reported after the close of the market on Wednesday that its first quarter revenues fell 22 percent year over year, mainly due to a non-recurring IP licensing agreement a year ago.

For the three months ended March 31, Rutherford, New Jersey-based Cancer Genetics posted total revenues of $1.4 million versus $1.8 million in the same quarter the year before. In Q1 2019, the firm had $300,000 in revenue from an IP license agreement that was unrelated to its ongoing discovery services business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.